EE03775B1 - Kopsusurfaktandi valgu SP-C sünteetilised peptiidanaloogid - Google Patents

Kopsusurfaktandi valgu SP-C sünteetilised peptiidanaloogid

Info

Publication number
EE03775B1
EE03775B1 EE9600175A EE9600175A EE03775B1 EE 03775 B1 EE03775 B1 EE 03775B1 EE 9600175 A EE9600175 A EE 9600175A EE 9600175 A EE9600175 A EE 9600175A EE 03775 B1 EE03775 B1 EE 03775B1
Authority
EE
Estonia
Prior art keywords
pct
image
surfactant protein
lung surfactant
synthetic peptide
Prior art date
Application number
EE9600175A
Other languages
English (en)
Other versions
EE9600175A (et
Inventor
P. Sch�fer Klaus
Nave R�diger
Ulrich Wolf-R�diger
Sturm Ernst
Kr�ger Uwe
H�fner Dietrich
Melchers Klaus
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6519392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03775(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE9600175A publication Critical patent/EE9600175A/et
Publication of EE03775B1 publication Critical patent/EE03775B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EE9600175A 1994-05-31 1995-05-27 Kopsusurfaktandi valgu SP-C sünteetilised peptiidanaloogid EE03775B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4418936A DE4418936A1 (de) 1994-05-31 1994-05-31 Polypeptid
PCT/EP1995/002028 WO1995032992A1 (de) 1994-05-31 1995-05-27 Synthetische peptidanaloge des lungenoberflächenproteins sp-c

Publications (2)

Publication Number Publication Date
EE9600175A EE9600175A (et) 1997-06-16
EE03775B1 true EE03775B1 (et) 2002-06-17

Family

ID=6519392

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600175A EE03775B1 (et) 1994-05-31 1995-05-27 Kopsusurfaktandi valgu SP-C sünteetilised peptiidanaloogid

Country Status (29)

Country Link
US (1) US5874406A (et)
EP (1) EP0764172B1 (et)
JP (1) JP3359638B2 (et)
KR (1) KR100355626B1 (et)
CN (1) CN1130374C (et)
AT (1) ATE275154T1 (et)
AU (1) AU690280B2 (et)
BG (1) BG63210B1 (et)
BR (1) BR9507811B1 (et)
CA (1) CA2191344C (et)
CY (1) CY2552B1 (et)
CZ (1) CZ286976B6 (et)
DE (2) DE4418936A1 (et)
DK (1) DK0764172T3 (et)
EE (1) EE03775B1 (et)
ES (1) ES2227548T3 (et)
FI (1) FI118126B (et)
HK (1) HK1000891A1 (et)
HU (1) HU220191B (et)
NO (1) NO317149B1 (et)
NZ (1) NZ287447A (et)
PL (1) PL181234B1 (et)
PT (1) PT764172E (et)
RO (1) RO118752B1 (et)
RU (1) RU2145611C1 (et)
SI (1) SI0764172T1 (et)
SK (1) SK282441B6 (et)
UA (1) UA35636C2 (et)
WO (1) WO1995032992A1 (et)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2322097A (en) * 1996-03-27 1997-10-17 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
DE19851119C2 (de) 1998-11-06 2001-05-31 Byk Gulden Lomberg Chem Fab Behälter und Vorrichtung zur Blindung der Verabreichung von nicht festen pharmazeutischen Darreichungsformen bei der klinischen Prüfung
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
AU5400000A (en) * 1999-06-11 2001-01-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
US7022671B1 (en) * 1999-06-17 2006-04-04 Altana Pharma Ag Surfactant protein C esters
WO2001019392A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
AU2003201A (en) * 1999-12-01 2001-06-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel use of lung surfactant
AU2001233757A1 (en) * 2000-02-11 2001-08-20 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
US6660833B1 (en) * 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
DE60118898T2 (de) * 2000-04-12 2006-11-16 Altana Pharma Ag Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
ATE468131T1 (de) 2001-10-11 2010-06-15 Nycomed Gmbh Neue verwendung von lungensurfactant
US6998384B2 (en) 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
JP5108515B2 (ja) 2004-08-06 2012-12-26 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 肺サーファクタント及びｔｎｆ由来ペプチドを含有する組成物
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
US7541331B2 (en) 2005-01-06 2009-06-02 Discovery Laboratories, Inc. Surfactant treatment regimen
DE102005014650B3 (de) 2005-03-31 2006-08-17 Altana Pharma Ag Anordnung aus Katheter und Anschlussstück sowie Ventil zum Durchführen eines Katheters
DE102005016229B3 (de) 2005-04-08 2006-06-14 Altana Pharma Ag Trockenvernebler
WO2008036293A1 (en) * 2006-09-19 2008-03-27 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
EP2009023A1 (en) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
CA2744940A1 (en) 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
WO2011029525A1 (en) 2009-09-08 2011-03-17 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
US9693955B2 (en) * 2010-08-23 2017-07-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Humidified particles comprising a therapeutically active substance
EP3459556A1 (en) * 2012-02-09 2019-03-27 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Synthetic analogs of lung surfactant protein sp-c and their use
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
WO2015132172A1 (en) 2014-03-05 2015-09-11 Takeda Gmbh Humidifier for humidifying an aerosol
WO2016170087A1 (en) 2015-04-22 2016-10-27 Chiesi Farmaceutici S.P.A Method and system for effective breath-synchronized delivery of medicament to the lungs
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
WO2016173634A1 (en) 2015-04-28 2016-11-03 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
CN107979996A (zh) * 2015-04-30 2018-05-01 不莱梅大学 新的皮肤医疗和美容护理产品
EP3490649A1 (en) 2016-07-28 2019-06-05 Chiesi Farmaceutici S.p.A. Method and system for delivery of an aerosolized medicament
CN109890446B (zh) 2016-10-26 2022-03-22 奇斯药制品公司 用于帮助通过导管向肺给送药剂的装置
AU2017384467B2 (en) 2016-12-22 2023-10-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving BPD
CN107163148A (zh) * 2017-05-15 2017-09-15 重庆理工大学 肺表面活性蛋白b前肽的重组蛋白及其制备方法和应用
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
JP7378425B2 (ja) 2018-04-23 2023-11-13 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 肺サーファクタントおよびｂｐｄの予防のためのステロイドを含む治療的組合せ
CN109001466A (zh) * 2018-07-19 2018-12-14 新疆维吾尔自治区人民医院 一种用于osa的肺表面活性蛋白试剂盒及其应用
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
EP4411745A1 (en) 2023-02-01 2024-08-07 Pari Medical Holding GmbH Medical evaluation method, aerosol nebulizer and medical evaluation system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
ATE163013T1 (de) * 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤

Also Published As

Publication number Publication date
KR970703367A (ko) 1997-07-03
RO118752B1 (ro) 2003-10-30
UA35636C2 (uk) 2001-04-16
CZ350296A3 (en) 1997-05-14
CA2191344A1 (en) 1995-12-07
EP0764172B1 (de) 2004-09-01
AU2616995A (en) 1995-12-21
FI964766A (fi) 1996-11-29
DE59510941D1 (de) 2004-10-07
ES2227548T3 (es) 2005-04-01
BR9507811B1 (pt) 2009-05-05
NO317149B1 (no) 2004-08-30
BR9507811A (pt) 1997-09-16
EE9600175A (et) 1997-06-16
HK1000891A1 (en) 2004-09-17
RU2145611C1 (ru) 2000-02-20
AU690280B2 (en) 1998-04-23
CY2552B1 (en) 2008-07-02
FI118126B (fi) 2007-07-13
NO965052D0 (no) 1996-11-27
US5874406A (en) 1999-02-23
BG63210B1 (bg) 2001-06-29
JP3359638B2 (ja) 2002-12-24
HU220191B (hu) 2001-11-28
DK0764172T3 (da) 2005-01-10
NZ287447A (en) 1998-01-26
SI0764172T1 (en) 2005-02-28
DE4418936A1 (de) 1996-02-08
BG101028A (en) 1998-01-30
FI964766A0 (fi) 1996-11-29
PL317420A1 (en) 1997-04-14
CZ286976B6 (en) 2000-08-16
WO1995032992A1 (de) 1995-12-07
CA2191344C (en) 2003-04-08
SK152496A3 (en) 1997-06-04
JPH10504025A (ja) 1998-04-14
PL181234B1 (pl) 2001-06-29
PT764172E (pt) 2005-01-31
HU9603249D0 (en) 1997-01-28
CN1130374C (zh) 2003-12-10
EP0764172A1 (de) 1997-03-26
CN1154117A (zh) 1997-07-09
KR100355626B1 (ko) 2002-12-26
SK282441B6 (sk) 2002-02-05
ATE275154T1 (de) 2004-09-15
MX9605986A (es) 1998-06-30
NO965052L (no) 1997-01-28
HUT76952A (hu) 1998-01-28

Similar Documents

Publication Publication Date Title
EE03775B1 (et) Kopsusurfaktandi valgu SP-C sünteetilised peptiidanaloogid
AU4188789A (en) Urethane-protected amino acid-n-carboxyanhydrides
DE69028671D1 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
TR199501630A2 (tr) Peptid p277 benzerleri ve diagnoz ve dibetlerin'lerin tedavisi icin onlari iceren kompozisyonlar.
ZA9510295B (en) Novel dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals
ES548052A0 (es) Procedimiento para preparar peptidos
GR3001922T3 (en) Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration
FI971427A0 (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
ATE42308T1 (de) Pharmakologisch aktive peptide.
HK1031664A1 (en) Use of an organ-specific nutritional composition
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
JPS649938A (en) Oral ingestive composition
AU7052191A (en) Antitumoral composition based on polypeptides having human interleukin 2 activity
CA2004764A1 (en) Ancrod proteins, their preparation and use
SE8501203D0 (sv) Mammal intestinal hormone precursor and its use
DE3689850D1 (de) Peptide und deren Verwendung in der Therapie.
ATE82504T1 (de) Herrichtung und verwendung eines physiologisch aktiven polypeptids zur aids-therapie.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231